Teleflex Incorporated

Study Highlights UroLiftâ„¢ System’s Advantages Over RezÅ«mâ„¢ in Treating BPH

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLiftâ„¢ System with RezÅ«mâ„¢ Water Vapor Therapy (WVTT) …

Study Highlights UroLiftâ„¢ System’s Advantages Over RezÅ«mâ„¢ in Treating BPH Read More


Teleflex Incorporated

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate

WAYNE, PA — A groundbreaking study published in the Nature journal Prostate Cancer and Prostatic Diseases has bolstered the position of the UroLiftâ„¢ System as the leading minimally invasive surgical …

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate Read More